Letter of Offer
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences has launched a buyback of up to 87.3 lakh equity shares (0.87% of paid-up capital) at INR 1,260 per share, totaling not more than INR 1,100 crore. The buyback runs from June 4 to June 10, 2026, via tender offer route on a proportionate basis. Record date was May 29, 2026. Small shareholders (holding up to INR 2 lakh worth) are reserved 15% of the offer, with entitlement ratio of 5 shares per 49 held, while general category gets 7 shares per 937 held. The buyback size is 5.16% of standalone and 3.84% of consolidated free reserves as of March 31, 2026, well within the 10% statutory limit. The buyback price was increased from the originally approved INR 1,150 per share.
The buyback offers a premium to shareholders at INR 1,260 per share, providing an immediate liquidity option. The tender offer structure with small shareholder reservation protects smaller investors. The INR 1,100 crore outlay is moderate relative to company reserves.